BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29882046)

  • 1. Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay.
    Châtel L; Yang X; Cholette F; Soudeyns H; Sandstrom P; Lavigne C
    Arch Virol; 2018 Oct; 163(10):2701-2710. PubMed ID: 29882046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection.
    Frank I; Acharya A; Routhu NK; Aravantinou M; Harper JL; Maldonado S; Sole Cigoli M; Semova S; Mazel S; Paiardini M; Derby N; Byrareddy SN; Martinelli E
    Sci Rep; 2019 Aug; 9(1):12078. PubMed ID: 31427605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Improved Tat/Rev Induced Limiting Dilution Assay With Enhanced Sensitivity and Breadth of Detection.
    Mehta K; Gohil Y; Mishra S; D'silva A; Amanullah A; Selvam D; Pargain N; Nala N; Sanjeeva GN; Ranga U
    Front Immunol; 2021; 12():715644. PubMed ID: 34421920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
    Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
    EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TILDA: Tat/Rev Induced Limiting Dilution Assay.
    Lungu C; Procopio FA
    Methods Mol Biol; 2022; 2407():365-372. PubMed ID: 34985676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.
    Lungu C; Procopio FA; Overmars RJ; Beerkens RJJ; Voermans JJC; Rao S; Prins HAB; Rokx C; Pantaleo G; Vijver DAMCV; Mahmoudi T; Boucher CAB; Gruters RA; Kampen JJAV
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32887284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches to assess HIV-1 persistence.
    Banga R; Procopio FA; Perreau M
    Curr Opin HIV AIDS; 2016 Jul; 11(4):424-31. PubMed ID: 27054279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.
    Pardons M; Baxter AE; Massanella M; Pagliuzza A; Fromentin R; Dufour C; Leyre L; Routy JP; Kaufmann DE; Chomont N
    PLoS Pathog; 2019 Feb; 15(2):e1007619. PubMed ID: 30811499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Charlins P; Schmitt K; Remling-Mulder L; Hogan LE; Hanhauser E; Hobbs KS; Hecht F; Deeks SG; Henrich TJ; Akkina R
    Virology; 2017 Jul; 507():135-139. PubMed ID: 28432928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.
    Avalos CR; Price SL; Forsyth ER; Pin JN; Shirk EN; Bullock BT; Queen SE; Li M; Gellerup D; O'Connor SL; Zink MC; Mankowski JL; Gama L; Clements JE
    J Virol; 2016 Jun; 90(12):5643-5656. PubMed ID: 27030272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
    Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
    Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
    de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
    AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.
    Jones LE; Perelson AS
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):483-93. PubMed ID: 17496565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
    Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
    PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.